Sellas Life Sciences Group Inc (SLS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$1.70B
EV to revenue ratio (TTM)
20.84
EV to ebitda
-1.71
Financial Performance
Revenue (TTM)
$0B
Gross profit (TTM)
$0.00B
EBITDA
n/a
Profitability
Operating margin (TTM)
<0.01%
Profit margin
<0.01%
Return on assets (TTM)
-23.30%
Return on equity (TTM)
-39.60%
Per Share Metrics
Revenue per share (TTM)
$0
EPS
-$0.21
Diluted EPS (TTM)
-$0.21
Book value
$0.68
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
26.90
Price to book ratio (TTM)
12.28
Growth
Quarterly earnings growth (YoY)
-82.50%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
1
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.70